Search | All Crowdz

Akash Motar added blog Other
2025-12-11 14:17:32 -

Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology
"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...

0 Comments 0 Shares 731 Views 0 Reviews

Please log in to like, share and comment!
John Werizon added blog Other
2026-02-19 12:23:12 -

Global Antibody Drug Conjugates (ADCs) Market Expands as Targeted Cancer Therapies Gain Momentum
The Antibody Drug Conjugates (ADCs) Market has moved from niche oncology innovation to one of the most closely watched segments in biopharmaceutical development. Once considered technically complex and commercially uncertain, ADCs now represent a validated therapeutic platform with multiple regulatory approvals and an expanding clinical pipeline. In simple terms, ADCs combine the...

0 Comments 0 Shares 229 Views 0 Reviews

Please log in to like, share and comment!
Ksh Dbmr added blog Networking
2026-03-16 06:27:38 -

How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?
Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

0 Comments 0 Shares 112 Views 0 Reviews

Please log in to like, share and comment!
Shim Carter added blog Other
2026-01-21 07:26:56 -

Myxoid Round Cell Liposarcoma (MRCLS) Drug Market – Precision Oncology Therapies, Rare Cancer Research & Clinical Pipeline
"Global Executive Summary Myxoid Round Cell Liposarcoma (MRCLS) Drug Market: Size, Share, and Forecast CAGR Value The Global Myxoid Round Cell Liposarcoma (MRCLS) Drug Market size was valued at USD 10.61 billion in 2024 and is expected to reach USD 14.3 billion by 2032, at a CAGR of 3.81% during the forecast period While preparing the first class Myxoid Round Cell Liposarcoma (MRCLS) Drug...

0 Comments 0 Shares 333 Views 0 Reviews

Please log in to like, share and comment!
Ksh Dbmr added blog Networking
2026-03-16 06:40:15 -

What Breakthrough Drug Delivery Technologies Are Fueling the Peptide-Drug Conjugate Therapeutics Market?
Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...

0 Comments 0 Shares 80 Views 0 Reviews

Please log in to like, share and comment!